Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsA study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.
A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.
Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.
1.
AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC
2.
AI-based liquid biopsy shows promise for detecting brain cancer
3.
Using MRD Status to Deescalate Multiple Myeloma Therapy
4.
A study on lung cancer provides additional proof of the value of screening.
5.
Can taking vitamin D supplements every day lower the mortality rate from cancer?
1.
The Danger of Methemoglobinemia and How to Prevent It
2.
The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer
3.
A Closer Look at the Effects of Sickle Cell on Eyesight
4.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
5.
The Role of Calcium Corrections in Accurate Blood Test Results
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge